Wahlgren, Mats
Goel, Suchi
Akhouri, Reetesh R.
Article History
First Online: 12 June 2017
Competing interests
: M. W. holds shares in, and is a director of the board of, Modus Therapeutics AB, a company of the Karolinska Development AB involved in the development of adjunct treatment for severe malaria and sickle-cell disease. The authors declare no other competing financial interests.